Free Webinar: Drawing NGS Plasma at Time of Lung Biopsy
CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]
22
May, 2020
21
Apr, 2020
Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology
Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology cfDNA levels correlate significantly with biomarkers of multiorgan damage in first abstract stemming from DOD research grant to [...]
17
Mar, 2020
CIRCULOGENE’s response to COVID-19
Dear All – I want to start this by saying Thank You! to all of our clients and staff members. Each day – with your efforts – you help hundreds of patients by giving them [...]
18
Feb, 2020
Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation
Current Trends in Clinical & Medical Sciences Chen Hsiung Yeh* Circulogene Theranostics, Birmingham, USA Received Date: January 24, 2020 Published Date: January 29, 2020 Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation Click here to [...]
17
Jun, 2019
CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury
$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel. BIRMINGHAM, Ala.--(BUSINESS [...]
25
Mar, 2019
CIRCULOGENE’s Precision Genomic Profiling Technology Featured in Three AACR 2019 Abstracts
Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing BIRMINGHAM, Ala.--(BUSINESS WIRE)-- CIRCULOGENE, advancing precision medicine through personalized [...]
13
Feb, 2019
CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation
BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part [...]
3
Jan, 2019
CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region
DATE: January 3, 2019 CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region Strategic partnership broadens cancer-targeted molecular diagnostics and immunotherapy testing to rapidly growing Asia-Pacific market. BIRMINGHAM, Ala.– CIRCULOGENE, advancing precision medicine through molecular genetics [...]
20
Dec, 2018
CIRCULOGENE to Launch Comprehensive, 20-Fusion NTRK Biomarker Testing in Early 2019
FOR IMMEDIATE RELEASE DATE: December 20, 2018 CIRCULOGENE to Launch Comprehensive, 20-Fusion NTRK Biomarker Testing in Early 2019 Proprietary, cfRNA-enriched, real-time PCR testing rapidly identifies all patients with NTRK fusion-positive cancers potentially eligible for new TRK [...]
19
Sep, 2018
CIRCULOGENE Expands Testing Menu with Somatic BRCA1/2 Blood Testing
CIRCULOGENE Expands Testing Menu with Somatic BRCA1/2 Blood Testing Enables paired somatic-germline testing, broadens targeted treatment population for breast, ovarian, pancreatic and prostate cancers BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through molecular genetics testing, has [...]